Peretz, Cheryl A. C.
Kennedy, Vanessa E.
Walia, Anushka
Delley, Cyrille L.
Koh, Andrew
Tran, Elaine
Clark, Iain C. http://orcid.org/0000-0001-9082-0253
Hayford, Corey E.
D’Amato, Chris
Xue, Yi
Fontanez, Kristina M.
May-Zhang, Aaron A. http://orcid.org/0000-0002-9017-0657
Smithers, Trinity http://orcid.org/0009-0008-5033-6000
Agam, Yigal
Wang, Qian
Dai, Hai-ping http://orcid.org/0000-0003-1125-7744
Roy, Ritu http://orcid.org/0000-0003-2065-7846
Logan, Aaron C. http://orcid.org/0000-0002-1179-5879
Perl, Alexander E.
Abate, Adam http://orcid.org/0000-0001-9614-4831
Olshen, Adam
Smith, Catherine C. http://orcid.org/0000-0003-0160-7026
Funding for this research was provided by:
Damon Runyon Cancer Research Foundation (CI-99-18)
Leukemia and Lymphoma Society
Foundation for the National Institutes of Health (K12CA260225)
Article History
Received: 10 November 2023
Accepted: 30 August 2024
First Online: 18 September 2024
Competing interests
: C.D., Y.X. and K.M.F. are employees of Fluent BioSciences whose technology was used for RNA–protein experiments. C.E.H. is a former employee of Fluent BioSciences. I.C.C. is a shareholder in Fluent BioSciences. A.A. is a co-founder and shareholder of Mission Bio, whose technology was used for DNA–protein experiments, and Fluent BioSciences. All other authors declare no potential conflicts of interest.